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Abstract A large variability in occurrence, complica-
tions, and age/gender manifestations characterizes indi-
vidual susceptibility of sporadic thoracic aortic aneu-
rysms (TAA), even in subjects with the same risk factor
profiles. The reasons are poorly understood. On the
other hand, TAA pathophysiology mechanisms remain
unclear than those involved in abdominal aorta aneu-
rysms. However, recent evidence is suggesting a crucial
role of biological ageing in inter-individual risk varia-
tion of cardiovascular diseases, including sporadic
TAA. Biological age rather than chronological age is a
better predictor of vascular risk. Relevant assumptions
support this concept. In confirming this evidence and
our preliminary data, the mean of blood leukocyte telo-
mere length, through use of terminal restriction frag-
ment assay and in blood samples from sporadic TAA
patients and controls, was examined. Telomerase activ-
ity was also analyzed in two groups. In addition, we
verified the weight of genetic inflammatory variants and
the major TAA risk factors in telomere/telomerase im-
pairment. Aorta histopathological abnormalities and
systemic inflammatory mediators were ultimately
correlated with telomere/telomerase impairment. Data
obtained demonstrated shorter telomeres and a reduced
telomerase activity in TAA patients significantly asso-
ciated with a genetic inflammatory risk profile, age,
gender, smoking, hypertension, a histopathological phe-
notype, and higher levels of systemic inflammatory
mediators than controls. In conclusion, telomere and
telomerase activity’s detection might be used as predic-
tor biomarkers of sporadic TAA. Their impairment also
suggests a strong role of vascular ageing in sporadic
TAA, evocated by both environmental and genetic in-
flammatory factors.
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Introduction
The medical research has as recent major objective to
determine the improving of life quality of people, and
particularly of aged individuals given the continuous
augment of ageing population phenomenon. This trend
determines several medical, economic, and social prob-
lems because of dramatic increase in the number of not
autonomous individuals affected by various pathologies
(Balistreri et al. 2013a). Among these, cardiovascular
diseases (CVD) have a disproportionate prevalence with
advancing age (Centers for Disease Control and
Prevention; National Center for Injury Prevention
Control. Available at: http://webappa.cdc.gov/cgi-bin/
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broker.exe. Accessed January, 2014Thus, the research
efforts are centered in reducing and/or retarding the onset
and progression of these diseases by searching new strat-
egies for early prevention and diagnosis, such as appro-
priate (molecular and genetic) biomarkers and new and
more efficient therapeutic treatments, i.e., the personalized
therapies (Ouzounian et al. 2007). This purpose seems to
be very ambitious, since these pathologies are character-
ized by a complex pathophysiology. In addition, their
mechanisms are not completely clear and prevalently
articulated in multistep clinical events, whose individual
probability, realization, and timing vary not only with risk
factors, but prevalently with the intrinsic ability of self-
artery-repair. Their progression is generally assumed as
irreversible and one-directional as a function of time.
However, for each step, a small reverse probability does
exist (Goldschmidt-Clermont et al. 2012). Some individ-
uals remain sheltered from the consequences of vascular
alterations, even in the presence of potent risk factors
(Goldschmidt-Clermont et al. 2012). This might be attrib-
uted to a substantial ability genetically determined for self-
repair of their arteries. As result, a large individual vari-
ability characterizes the susceptibility of all CVD diseases,
such as sporadic thoracic aortic aneurysms (TAA). In the
case of sporadic TAA, a silent illness and insidious in its
onset and progression, several cardiovascular risk factors
(i.e., age, gender, hypertension, oxidative stress, smoking,
etc.) seem to explain a large amount of its susceptibility in
the general population (Ince and Nienaber 2007; El-
Hamamsy and Yacoub 2009; Elefteriades and Farkas
2010). At an individual level, there is a wide variation in
both its occurrence and complications (i.e., dissection and
rupture) and age/gender related manifestations, even in
individuals with the same risk factor profiles (Ince and
Nienaber 2007). Recent lines of evidence sustain that the
rate of biological age may be the principal cause of inter-
individual CVD risk variation. Biological age rather than
chronological age is a better predictor of vascular risk
(Epel et al. 2008; Huzen et al. 2010; Mainous and Diaz
2010; Saliques et al. 2010; De Meyer et al. 2011;
Fitzpatrick et al. 2011; Fyhrquist et al. 2013). This as-
sumption is based on the relevant data of Wilson and
colleagues (Wilson et al. 2008). They evidenced as the
telomere content (the TTAGGG DNA repeats at the ends
of chromosomes (Blackburn 2010)) in circulating blood
leukocytes accurately reflects the biological age of the
vascular wall. Consistent with these observations, a series
of recent studies demonstrated significant associations
between the reduction of telomere leukocyte length and
the risk of several CVDs, such as aorta aneurysms. In
particular, Atturu and colleagues observed that short leu-
kocyte telomere length is associatedwith abdominal aortic
aneurysm, by examining a European population and eval-
uating the mean terminal restriction fragment (TRF)
length, a marker of telomere length (Atturu et al. 2010).
Yan and colleagues demonstrated a significant shorter
leukocyte telomere length in a Chinese population affect-
ed by aortic dissection (Yan et al. 2011). Precisely, they
detected a decreased telomere length ratio (T/S ratio) in 72
cases vs. 72 controls, by using a quantitative PCRmethod.
No association was evidenced for multiple aneurysms in
another European study (Björck et al. 2011). In previous
studies, we recently obtained promising results by com-
paring the mean of TRF length in cases affected by
sporadic TAA and controls. In particular, shorter telo-
meres were detected in cases than in controls (Balistreri
et al. 2012; Ruvolo et al. 2014). Subsequently to our study,
only the group of Salonurmi analyzed the telomere length
in TAA aneurysms, surprisingly demonstrating opposite
results. Precisely, they evaluated the relative lengths of
telomeres by using the Cawthon’s quantitative PCRmeth-
od in a Finnish population, and they observed longer
telomeres in the cases than healthy age matched controls
(Huusko et al. 2012).
Recently, an impairment of telomerase activity has
been also assessed in aorta aneurysms by two recent
studies (Dimitroulis et al. 2011; Findeisen et al. 2011).
In contrast, until now there are no reports in the
literature about the biological effects mediated by ge-
netic and environmental factors in the impairment of the
telomere/telomerase system in aorta aneurysms, and
particularly in sporadic TAA. This is a very interesting
topic. It is well recognized that the rate of vascular
ageing is the result of a complex interaction between
genetic and environmental factors (O’Rourke et al.
2011; Laurent 2012; Nilsson 2012; Bachschmid et al.
2013). On the other hand, in all CVDs (TAAs included),
genetic component seems to play a key role. In the
recent years of post-human genome sequencing project,
this is confirmed by non-biased techniques (i.e.,
genome-wide association studies). In particular, they
have discovered CVD-relevant genes, which are not
associated with previously suspected pathways of lipid
metabolism, diabetes, or hypertension. Their major
number is prevalently associated with inflammation
(such as genes related to TLR4-mediated signaling path-
way) and stem cell biology (i.e., that of endothelial
progenitor cells). Only a minority of implicated CVD-
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genes are linked to lipid and other classical risk factor
pathways (Incalcaterra et al. 2013). This underlines the
crucial influence of inflammation on the rate of biolog-
ical vascular ageing and its complications, such as vas-
cular remodeling and medial degeneration, the typical
pathological entities of several aorta diseases, including
sporadic TAA. Among the genes able to modulate in-
flammation, genes related to TLR4-mediated signaling
pathway have been associated with the susceptibility for
several CVDs (Balistreri et al. 2004, 2009, 2013b, c;
Frantz et al. 2007; Ionita et al. 2010; Hofmann et al.
2011; Navi et al. 2013; Incalcaterra et al. 2013). In our
recent study (Ruvolo et al. 2014), we have also demon-
strated their role in sporadic TAA. This is in agreement
with current evidence, which points to the functional
importance of TLR4-mediated signaling pathway in
mediating physiological aorta homeostasis and the
maintaining of protection against pathogens and damage
cell molecules, as well as in inducting pathological aorta
phenotypes. On the other hand, it is increasing the
opinion to consider aortic aneurysms, and particularly
the sporadic forms of TAA, as inflammatory/immune
diseases with a strong genetic component (Kuivaniemi
et al. 2008).
Based on these observations and our preliminary and
promising results (Balistreri et al. 2012; Ruvolo et al.
2014), we detected the eventual telomere/telomerase
system’s impairment in a larger number of cases affected
by sporadic TAA and age/gender matched controls. We
also analyzed the potential influence of ten polymor-
phisms related to TLR4-mediated signaling pathway
and major TAA risk factors in telomere/telomerase im-
pairment. Aorta histopathological abnormalities and
systemic inflammatory mediators were ultimately cor-
related with telomere/telomerase impairment.
Materials and methods
Patients and controls
Our study included a group of 80 patients [55 men
(69 %) and 25 (31 %) women; mean age 63±11.6]
affected by sporadic TAA, as confirmed by histopatho-
logical analyses and exclusion criteria for syndromic
and familial forms (e.g., Marfan and Ehler’s Danlos
syndromes) and autoimmune connective tissue disor-
ders. They randomly were selected by a cohort of 161
individuals [127 men (78 %) and 34 (22 %) women;
mean age 63±10.7] from Western Sicily, previously
enrolled and analyzed in our recent studies (Pisano
et al. 2012a, b; Balistreri et al. 2013b, c; Ruvolo et al.
2014). The sporadic TAA diagnosis was performed
through imaging technologies (i.e., ECHO, CT, and
MRI). The aneurysm’s localization essentially was in
the ascending aorta (precisely in the aortic sinus and
tubular portion and sometimes only in the tubular por-
tion) and aortic bulb, or both.
Medical histories pertinent to aortic disease were
obtained from patient’s medical records. Thus, demo-
graphic and clinical features, comorbidity conditions,
and pharmacological treatments were collected
(Table 1).
An equal number of controls [N=80; 55 men (69 %)
and 25 (31 %) women; mean age 61±8.5] was included
in this study, randomly selected by a cohort of healthy
controls previously enrolled and studied in our previous
studies, as the case’s group (Pisano et al. 2012a, b;
Balistreri et al. 2013b, c, 2014a, b; Ruvolo et al. 2014)
(Table 1).
Patients and controls belonged to same ethnic group,
since their parents and grandparents were born in Sicily.
No statistically significant differences were observed
analyzing the case and control features as summarized
in Table 1, with the exception of smoking and hyper-
tension (42 vs. 18, p=0.00008, and 48 vs. 18, p=
0.000001, by χ2 test, respectively). In particular, hyper-
tension characterized the 60 % of patients opportunely
treated with medications like ACE inhibitors and beta-
blocker etc. during the follow-up and after surgery.
Our study received approval from the local ethics
committees, and all participants gave their informed
consent. Data were encoded to ensure the anonymity
of patients in the study and control groups. All measure-
ments were performed without knowledge of the nature
of the study.
Telomere length assay
DNA samples of 80matched controls and 80 cases were
extracted from peripheral blood samples collected in
tripotassium EDTA and purified by using a QIAamp
Blood DNA Maxi kit (Qiagen, Dusseldorf, Germany).
The mean terminal restriction fragment (TRF) length, a
marker of telomere length, was measured through a
chemiluminescence technique and using the
TeloTAGGG telomere length assay kit (Roche
Diagnostics, Indianapolis, USA), according to the
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manufacture’s protocol. In brief, 25 μl of each DNA
sample (75 ng/μl) was digested with 10 U of Rsa I
(Invitrogen Ltd, UK) and 10 U of Hinf I (Invitrogen
Ltd, UK) at 37 °C for two and a half hours. The DNA
fragments were separated by electrophoresis on 0.6 %
agarose gels (20×20 cm) at 150 V for 1 h and 50 V for
18 h. The DNAwas then depurinated with 0.25 % HCl
for 20 min, denatured with 0.5 mol/L NaOH/1.5 mol/L
NaCl for 30 min, and neutralized with 0.5 mol/L
Tris/1.5 mol/L NaCl, pH 8 for 30 min. The DNA was
transferred overnight onto a positively charged nylon
membrane (Roche Diagnostics, Indianapolis, USA)
using a southern blot technique and fixed with ultravio-
let light. The membrane was then hybridized with a
telomere repeat-specific digoxigen (DIG)-labeled probe
overnight at 42 °C. The membrane was washed three
times with 2×saline sodium citrate (SSC)/0.1 % sodium
dodecyl sulfate (SDS) followed by 0.2×SSC/0.1 %
SDS. The membrane was then incubated with a DIG-
specific antibody covalently coupled to alkaline phos-
phatase. The immobilized telomere probe was then vi-
sualized using CDP star, a highly chemiluminescent
substrate for alkaline phosphate. Exposing the mem-
brane to an autoradiograph film (Roche Diagnostics,
Indianapolis, USA) revealed the telomere smears. The
mean terminal restriction fragment of each sample was
calculated using the formulamean TRF=TRF=(∑(iOD))/
(∑(iOD/Li)), where ODi is the optical density at a given
position on the gel and Li is the molecular weight at that
position. An internal control with a known mean TRF
length (DNA extracted from HUVEC cells) was used to
study the inter-gel and intra-gel variation in mean TRF
length (data not shown). Themean TRF length of samples
from cases and controls were adjusted to the standardized
internal control to account for the inter-gel and intra-gel
variation (see Fig. 1).
Detection of telomerase activity by TRAP assay
For quantitative analysis of telomerase activity, a
Telomeric Repeat Amplification Protocol (TRAP)
(Kim and Wu 1997) and a photometric enzyme im-
munoassay were performed using TeloTAGGG
Telomearse PCR ElisaPlus kit (Roche Diagnostics,
Indianapolis, USA), according to the manufacturer’s
protocol. This precisely involved elongation and am-
plification of telomerase reaction products to allow
highly sensitive detection of telomerase activity by a
photometric enzyme immunoassay. Briefly, we firstly
obtained pellets of blood peripheral leukocytes. They
were lysed directly in sterile reaction tubes using the
lysis buffer provided in the kit. Protein lysate was
kept on ice for 30 min and centrifuged at 16,000g
for 20 min at 2–8 °C. Protein concentration was
measured by standard methods. Subsequently, the
supernatants obtained were utilized in quantity of
0.5–10 μg total protein for the TRAP reaction, having
the assurance to prepare for each sample a negative
Table 1 Demographic and clini-
cal characteristics, comorbodity
conditions, and pharmacological
treatment of 80 patients affected
by sporadic TAA, 80 control
subjects
Bold entries The unique features
of patients and controls, which are
significantly different, are
smoking andhypertension
Variables Patients Controls P1 (cases vs. controls)
N=80 N=80
Demographic characteristics
Age, mean (SD) 63 (11.6) 61 (8.5) NS
Body mass index, mean (SD) 26.9 (3.9) 26.7 (1.8) NS
Size and location
Size (mm), mean (SD) 53.5 0 (0)
Location, no. (%): 0 (0)
Ascending aorta 62 (85)
Aortic bulb 12 (15)
Comorbidity conditions, no. (%)
Smoking 42 (53) 18 (23) 0.00008
Hypertension 48 (60) 18 (23) 0.000001
Dislipidemy 12 (15) 8 (10) NS
Diabetes mellitus 10 (13) 8 (10) NS
Renal failure 5 (6) 0 (0) NS
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control by heat inactivation of its aliquot at 85 °C for
20 min. In performing the TRAP reaction, high con-
trol template (concentration 0.1 amol/μl; quantity
used for each reaction 1 μl), a reaction mixture
(25 μl for each sample), and an internal standard
(IS; 5 μl for each sample) provided in the kit were
also utilized. Thus, sterile tubes (each containing a
total of 30 μl of the master mix-25 μl of reaction
mixture and 5 μl of IS and a suitable volume of each
negative or positive sample or 1 μl of control tem-
plate) were transferred to a thermal cycler (MyCycler,
Biorad). A combined primer elongation/amplification
reaction was performed by the following protocol:
primer elongation 10–30 min at 25 °C 1 cycle; telo-
merase inactivation 5 min at 94 °C 1 cycle; amplifi-
cation (denaturation 30 s at 94 °C; annealing 30 s at
50 °C; polymerization 90 s at 72 °C) for 30 cycles;
10 min at 72 °C for 1 cycle; hold at 4 °C. During the
reaction, telomerase add telomeric repeats (TTAG
GG) to the 3’ end of the biotin-labeled primer. The
elongation products, as well as the IS included in the
same reaction tube, are then amplified. The PCR
products were split into two aliquots, denatured,
bound to a streptavidin-coated 96-well plate, and hy-
bridized to a digoxigenin (DIG)-labeled telomeric
repeat-specific probes, specific for the telomeric re-
pea ts and IS. The resul t ing products were
immobilized via the biotin label to streptavidin-
coated 96-well microplate. Immobilized amplicons
were then detected with an antibody against
digoxigen that is conjugated to horseradish peroxi-
dase (anti-DIG-HRP) and the sensitive peroxidase
substrate TMB. Sample absorbance was measured at
450 nm (reference wavelength 690 nm) using an
ELISA plate reader within 30 min after the addition
of the stop reagent. Absorbance values were then
utilized to calculate the relative telomerase activity
(RTA) of each sample using an appropriate formula
provided in the kit’s protocol.
Aortic specimens, histopathological
and immunohistochemical assays, TUNEL testing,
and genotyping
Aorta samples as well as DNA samples of individuals
selected in our study were collected, obtained, and
Fig. 1 A film of
chemioluminescence detection of
the mean leukocyte TFR length
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analyzed in our previous studies (Pisano et al. 2012a, b;
Balistreri et al. 2013b, c, 2014a, b; Ruvolo et al. 2014).
The procedures, criteria, definitions, and grading sys-
tems for tissue sample collection, staining, histopatho-
logical and immunohistochemical assessment, Terminal
deoxynucleotidyl transferase dUTP Nick End Labeling
(TUNEL) testing, and genotyping of ten polymor-
phisms related to TLR4-mediated signaling pathway
were previously described in our studies (Pisano et al.
2012a, b; Balistreri et al. 2013b, c, 2014a, b; Ruvolo
et al. 2014). Thus, data previously obtained were com-
pared and correlated with telomere/telomerase impart-
ment between cases and controls.
Statistical analysis
All analyses were performed with R and Microsoft
Excel software. Significant differences between
qualitative variables were calculated by using
Pearson χ2 test. Furthermore, odds ratios (OR) with
95 % confidence intervals (CI) and their signifi-
cance were calculated. The difference in mean
TRF length and the mean values of RTA between
cases and controls was analyzed using the unpaired
t test with Welch correction. The difference in mean
TRF length and the mean values of RTA in subjects
with different risk factors was analyzed using bi-
variate correlation for continuous variables and an
independent samples t test for categorical variables.
The differences in systemic inflammatory mediators
between the two groups were also detected by the
unpaired t test with Welch correction. The indepen-
dent effect of the risk factors on the mean TRF
length and the mean values of RTA was analyzed
using a linear regression model controlling for
case–control status. To identify possible correla-
tions, a non-parametrical Spearman correlation test
was also used.
Allele and genotype frequencies were evaluated by
gene count. Data were tested for goodness of fit between
observed and expected genotype frequencies according
to the Hardy-Weinberg equilibrium, by χ2 tests.
Significant differences in frequencies among groups
were calculated by using χ2 test and appropriate tables
(2×2 and 3×2 tables etc. where appropriate).
Analysis of variance (ANOVA) test (corrected by
Bonferroni) was also utilized to compare positive
inflammatory/immune cells between case and control
aorta samples.
Results
Evaluation of the mean TRF length in cases
and controls, correlation with risk factors, and detection
of independent effects of risk factors on telomere
impairment
The evaluation of the mean TRF length in the two
groups and their analysis demonstrated that the mean
TRF length of the case’s group (5,189, standard devia-
tion [SD]=0.367 kbp) was significantly lower than that
observed in the control group (6,238, SD=0.128 kbp).
A difference of 1,049 bp was observed between cases
and controls (95 % confidence interval [CI] 37–107 bp,
p<0.0001, by t test) (Fig 2). In addition, correlations
were detected between the mean TRF length and age in
both patients and controls (2.6 bp decrease per year,
SD=2.1; p=0.03) and between the mean TRF length
and aneurysm size (p=0.045) among the cases. The
comparisons of mean TRF length values between male
and female patients demonstrated a significant reduction
in woman (5,337, SD=0.119 kbp vs. 5,012, SD=0.239;
p=0.0001 by t test Welch corrected). Significant differ-
ences were also observed in mean TRF length between
male patients and male controls (5,337, SD=0.119 kbp
vs. 6,402, SD=0.130 kbp; p<0.0001 by t test Welch
corrected). A significant decrease was also assessed in
female cases vs. female controls (5,012, SD=0.239 vs.
6,202, SD=0.345 kbp; p<0.0001 by t test Welch
corrected). Furthermore, we analyzed the independent
effects of risk factors including age, gender, smoking,
hypertension, diabetes, dislipidemy, and renal failure on
the mean TRF length among the subjects. As indepen-
dent risk factors, age, smoking, and hypertension in
cases were the unique risk factors significantly associ-
ated with the mean TRF length (p=0.02, p=0.002, and
p=0.001, respectively). The case’s subjects with
smoking and hypertension histories had a significantly
shorter mean TRF length (5,089, SD=0.089) compared
to subjects without these risk factors (5,521, SD=0.112)
(mean difference 432 bp, CI 8–228 bp, p=0.01) Fig. 3.
Relative telomerase activity in cases and controls,
correlation with risk factors, and detection
of independent effects of risk factors on telomerase
activity
The analysis of the mean values of RTA in the cases and
controls demonstrated significant differences (7.8±2.6
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Fig. 2 The mean terminal restriction fragment (TFR) length in the two cohorts. In black sporadic TAA cases; in white controls
Fig. 3 The mean RTA values in the two groups. In black sporadic TAA cases; in white controls
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vs. 62.15±8.9, p<0.0001 by t test Welch corrected). In
addition, correlations were assessed between the RTA
mean values and age in both patients and controls
(p=0.038), and between the RTA mean values and
aneurysm size (p=0.03) among the cases. The compar-
isons of RTA mean values between male and female
patients demonstrated a weak decrease in women (6.9±
9.1 vs. 5.3±13.2). Significant differences were observed
in RTA mean values between male patients and male
controls (6.9±9.1 vs. 61.8±4.8; p<0.0001 by t test
Welch corrected), and in female cases vs. female con-
trols (5.3±13.2 vs. 60.5±6.7; p<0.0001 by t test Welch
corrected). Furthermore, the analysis of the independent
effects of risk factors including age, gender, smoking,
hypertension, diabetes, dislipidemy, and renal failure on
RTA mean values among the subjects demonstrated that
age, smoking, and hypertension in cases were the
unique risk factors significantly associated with RTA
mean values (p=0.032, p=0.02, and p=0.001,
respectively).
Assessment of weight of biological effects mediated
of inflammatory genetic factors in the impairment
of telomere/telomerase system in cases and controls
As above reported, the (80 cases and 80 controls) sub-
jects in study were selected by 161 cases and 128
controls previously genotyped for ten TLR4 pathway-
related genetic variants (see Ruvolo et al. 2014). By
analyzing the genotype distribution and allele frequen-
cies of these variants in 80 cases and 80 controls, sig-
nificant associations were found for the rs4986790
(+896A/G; Asp289Gly) TLR4, overrepresented in the
cases than controls (Table 2). No significant differences
were also detected stratifying the frequencies for gender
(data not shown). However, in order to identify a
possible combined genotype as risk profile, the differ-
ences in the frequencies of all possible combinations of
combined genotypes of these variants were assessed.
Interestingly, we detected that the +896ATLR4/DACE/
-1562TMMP-9/-735TMMP-2 genotype, comparing it
with the frequency of other combinations, was the
unique combined genotype significantly represented in
cases than controls (Table 3). This combined genotype
(defined in our previous study as high responder
genotype, given the biological effects of these alleles;
see Ruvolo et al. 2014) was found in 25 % of cases,
while only 10% of controls had this combined genotype
(p=0.01 by χ2 test, 2×2 table; Table 3). Cases bearing
high responder genotype had a mean TRF length and
mean RTA values significantly reduced than controls,
and compared to those of both controls and patients
with other genotypes (see Table 4). In addition, they
showed higher levels of plasma inflammatory media-
tors than controls and patients without or with high
responder genotype (Table 4). The patients with high
responder genotype also presented a higher amount of
CD3+CD4+CD8+CD68+CD20+ cells than patients
with other genotypes and control aortas (Fig. 4)
Furthermore, positive correlation was also identified
between the reduction of mean TRF length observed
from samples of patients bearing high responder ge-
notype and the histological abnormalities observed
through histopathological and immunohistochemical
assays and Tunel testing (Table 5). In particular, the
data obtained underlined that patients with high re-
sponder genotype showed a higher severity of histo-
logical abnormalities with the reduction of mean TRF
length. Their grading and their morphological and
histological entity characterized a typical tissue aorta
phenotype which we defined in a previous study as
phenotype III.
Table 2 Genotype distributions and allele frequencies of +896A/G TLR4 SNP in 80 S-TAA patients and 80 matched controls (2×2
comparisons between the different groups with odd ratio (OR) and 95 % confidence interval)
Candidate gene Reference SNP number Candidate SNPs Patients
(N=80)
Matched
controls
(N=80)
p (3×2, 2×2 tables) OR (95 % CI)
TLR4 rs4986790 +896A/A 78 97.5 % 70 87 % 0.04 6.4 (1.4–29.1) p=0.005
+896A/G 2 2.5 % 8 10 %
+896G/G 0 0 % 2 3 %
+896A 158 99 % 148 92.5 % 0.01
+896G 2 1 % 12 7.5 %
All genotypes were in Hardy-Weinberg equilibrium
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Discussion
Ongoing and recent evidence is considering biological
age as a principal risk factor for individual CVD sus-
ceptibility, even if the related molecular and cellular
mechanisms remain unclear (Epel et al. 2008; Huzen
et al. 2010; Mainous and Diaz 2010; Saliques et al.
2010; De Meyer et al. 2011; Fitzpatrick et al. 2011;
Fyhrquist et al. 2013). Cardiovascular dysfunction and
its complications, i.e., the onset of different CVDs (spo-
radic TAA included), are associating with the senes-
cence of cardiovascular tissues as result of telomere
shortening, DNA damage, and genomic instability
(Minamino and Komuro 2008). On the other hand, the
replicative ability of cardiovascular cells, particularly
stem cells and/or progenitor cells, has been shown to
decline with age (Minamino and Komuro 2008).
Accordingly, telomere attrition, recognized as the best
ageing biomarker, is now assuming as predictor for
CVDs, including sporadic TAA (Epel et al. 2008;
Huzen et al. 2010; Mainous and Diaz 2010; Saliques
et al. 2010; DeMeyer et al. 2011; Fitzpatrick et al. 2011;
Fyhrquist et al. 2013). This concept is supported by key
assumptions. It has been demonstrated by Wilson and
colleagues (2008) that the telomere content in peripheral
blood leukocytes accurately reflects that of the vascular
wall, and its decrease is associated with premature vas-
cular disease. Based on these observations, we investi-
gated whether blood leukocyte telomere content and
telomerase activitymight also be considered as predictor
biomarkers for sporadic TAA. Interesting results were
obtained. In particular, we detected a shorter leukocyte
TRF mean length and reduced mean RTA values in
cases than controls. Stratifying the data for gender, male
and female patients showed a significant increased
telomere/telomerase system impairment when com-
pared to controls. A raised telomere attrition was also
assessed between female and male patients. In addition,
the comparisons of RTA mean values between male and
female patients demonstrated a weak decrease in wom-
en. Correlations were also detected between the
telomere/telomerase system impairment and age, and
aneurysm size in cases. Age as independent risk factor
was also associated with telomere/telomerase
Table 3 Frequency of +896ATLR4/DACE/-1562TMMP-9/-735TMMP-2 genotype between patients and controls (2×2 comparisons
between the different groups with odd ratio (OR) and 95 % confidence interval)
Patients (N=80) +896ATLR4/DACE/-1562TMMP-9/-735TMMP-2 Other genotypes p (2×2 Table) OR (95 % CI) (1.2–7.2)
20 (25 %) 60 (75 %)
p=0.01 p=0.01
Controls (N=80) 8 (10 %) 72 (90 %)
Table 4 Mean TRF length, mean values of RTA, systemic plasma mediator’s levels in patients, and controls with high responder genotype
or other genotypes
Evaluations Patients with
high responder
genotype (N=20)
Controls with
high responder
genotype (N=8)
Patients with
other genotypes
(N=60)
Controls with
other genotypes
(N=72)
P1 values* P2 values** P3 values***
Mean TRF length 5,106±0.125 bp 6,210±0.345 bp 5,290±0.195 bp 6,790±0.635 bp <0.0001 <0.0001 <0.0001
Mean RTA values 6.3±4.8 58.2±10.7 7.1±1.9 62.5±9.2 0.005 <0.0001 <0.0001
IL-6 (pg/ml) 13.8±1.9 9.1±2.9 10.1±2.9 6.3±1.2 0.01 <0.0001 0.002
TNF-α (pg/ml) 16.1±1.8 8.1±3.4 12.6±1.7 6.9±2.1 <0.0001 <0.0001 <0.0001
CRP (mg/l) 16.8±5.4 4.3±1.6 12.1±2.5 3.6±1.8 <0.0001 <0.0001 <0.0001
MMP-2 (ng/ml) 58.9±1.9 10.6±1.5 51.7±4.9 8.5±1.7 <0.0001 <0.0001 <0.0001
MMP-9 (ng/ml) 59.1±4.9 10.25±1.8 56.1±1.5 9.5±4.2 <0.0001 <0.0001 <0.0001
By unpaired t test with Welch correction
*P1 values obtained comparing patients with high responder genotype vs. controls with high responder genotype
**P2 values obtained comparing patients with high responder genotype vs. controls with other genotypes
***P3 values obtained comparing patients with high responder genotype vs. patients with other genotypes
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impairment. This might emphasize that with advancing
age, the rate of biological age and consequently vascular
ageing increase. In addition, we demonstrated that
smoking and hypertension, other crucial risk factors,
are independent factors significantly associated with
the reduction of both leukocyte TRF length and RTA.
These findings are in agreement with the relevant data
recently published by Huzen and colleagues. They mea-
sured leukocyte telomere length by quantitative poly-
merase chain reaction in 8,074 participants from the
Prevention of Renal and Vascular End-stage Disease
Study (Huzen et al. 2014). Their relevant data evidenced
that the major independent factors of telomere attrition
in humans were smoking and metabolic syndrome.
Confirmation of these data derives by further studies
of Chinese, Indian, and Finnish researchers that evi-
denced as hypertension is a significant contributor in
telomere attrition (Yang et al. 2009; Fyhrquist et al.
2011; Bhupatiraju et al. 2012). Thus, these data encour-
age to propose as the complex interplay between the
environmental and genetic factors can determine the
senescence of cardiovascular cells and the onset of
CVDs, i.e., sporadic TAA. In particular, it is also possible
to speculate that the senescence of cardiovascular cells
might also be the result of the combined action of two
mechanisms genetically acquired: genetically substantial
inability in self-repair of the cardiovascular system and a
genetically acquired ability to have a sustained
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Fig. 4 Morphometric quantization of lymphocytes, Tcell subpop-
ulations, and macrophages in aorta samples of cases with high
responder genotype, other genotypes, and controls. CD3, CD4,
CD8, CD20, and CD68 positive cells in media and adventitia in 10
contiguous high-power fields (magnification ×400) were counted
by two independent observers. Significant increased amounts of
CD3+CD4+CD8+CD68+CD20+ cells were observed by com-
paring their values among the three groups (by ANOVA test). In
particular, cases with high responder genotype had higher numbers
of these cells than controls and cases with other genotypes
Table 5 Correlations between the reduction of mean TRF length observed from samples of patients bearing high responder genotype and
the severity of histological abnormalities observed through histopathological and immunohistochemical assays and Tunel testing
Variables Correlations P valuesa
Medionecrosis of grade III 0.218 0.002
Cystic-medial change of grade III 0.227 0.001
Elastic fragmentation of grade III 0.356 0.0001
Plurifocal medial apoptosis 0.117 0.001
Elevated MMP-9 amounts 0.263 0.001
a by non-parametrical Spearman correlation test
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inflammatory response. Reciprocally, a strong genetically
acquired ability in self-repair of the cardiovascular system
and a blunted inflammatory response genetically induced
might justify the individual probability to remain sheltered
from the consequences of vascular alterations and the large
individual variability in the susceptibility of all CVD dis-
eases, such as sporadic TAA, even in the presence of
potent risk factors. In particular, these suggestions
underlined as inflammation can influence both the rate of
biological vascular ageing and its complications, such as
vascular remodeling and medial degeneration, the typical
features of several aorta diseases, including sporadic TAA
(Phan et al. 2008; Fulop et al. 2010; Wadley et al. 2013).
On the other hand, it is increasing the opinion to consider
aortic aneurysms, and particularly the sporadic forms, as
inflammatory/immune diseases with a strong genetic com-
ponent (Kuivaniemi et al. 2008). Accordingly, we also
evaluated the weight of genetic variants in inflammatory
genes in influencing telomere/telomerase impairment. In
particular, we focused our attention on ten variants in genes
related to TLR4-mediated signaling pathway (Balistreri
et al. 2009; Ruvolo et al. 2014), since in a previous study
we have observed a significant association between a
combined risk (+896ATLR4/DACE/-1562TMMP-9/-
735TMMP-2) genotype and sporadic TAA. It was also
associated with an increased systemic and local inflamma-
tion and aorta histopathological abnormalities. On the
other hand, an increasing number of studies underlines
the involvement of this signaling pathway in several
CVDs (Balistreri et al. 2004, 2009, 2013b, c; Frantz et al.
2007; Ionita et al. 2010; Hofmann et al. 2011; Navi et al.
2013; Incalcaterra et al. 2013). Its role in age-related aorta
dysfunction and the aneurysm formation and related com-
plications (dissection or rupture) recently is emerging
(Pryshchep et al. 2008; Eissler et al. 2011; Li et al. 2011;
Song et al. 2012; González-Ramos et al. 2013; Navi et al.
2013; Ruvolo et al. 2014). A current report demonstrated
its expression in all cells of the arterial wall, and particu-
larly in the endothelium and vascular smooth cells, by
suggesting its functional importance in mediating physio-
logical homeostasis and maintaining protection, but also in
inducing pathological aorta phenotypes (Pryshchep et al.
2008). Recent experimental investigations in animal and
ex vivomodels also emphasize its role in the vascular aorta
alterations (i.e., vascular remodeling and medial degener-
ation) and their complications, such as sporadic TAA
(Pryshchep et al. 2008; Eissler et al. 2011; Li et al. 2011;
Song et al. 2012; González-Ramos et al. 2013; Navi et al.
2013; Ruvolo et al. 2014).
Among the ten genetic variants related to TLR4-
mediated signaling pathway, only the rs4986790 (+
896A/G) TLR4 variant was overrepresented in the cases
than controls. No significant differences were also detected
stratifying the frequencies for gender. Furthermore, we
identified a combined +896ATLR4/DACE/-1562TMMP-
9/-735TMMP-2 genotype as risk profile, significantly rep-
resented in cases than controls. Cases bearing this com-
bined genotype (defined in our previous study as high
responder genotype, given the biological effects of these
alleles; see Ruvolo et al. 2014) had amean TRF length and
mean RTAvalues significantly reduced than those of con-
trols, and respect to those of both controls and patients with
other genotypes. In addition, they showed higher levels of
systemic inflammatory mediators, a higher amount of
CD3+CD4+CD8+CD68+CD20+ cells, positive correla-
tion between the reduction of mean TRF length and the
histological abnormalities (including elevated cystic
medial degeneration, elevated elastic fragmentation,
plurifocal medial apoptosis, and increased amounts of
metalloproteinase-9) of a characteristic phenotype defined
in our previous studies as phenotype III, and associated
with an increased risk of rupture or dissection, indepen-
dently of aneurism size. Thus, our findings seem to suggest
the relevant role of the genetic inflammatory variants of
TLR4 pathway in contributing to induced senescence of
cardiovascular cells and, as consequence, vascular aorta
ageing and alterations associated with the onset of CVDs,
and, in the case specific, with sporadic TAA. Certainly,
their interplay with environmental factors, such as princi-
pally smoking and life-factors influencing hypertension,
i.e., diet and reduced physical exercise, plays a crucial role.
On the other hand, the biological effects of functional
genetic variants depend on the presence of one or different
environmental causes. Because of this relationship be-
tween genetic and environmental factors, a genetic variant
might never manifest itself phenotypically, if the carrier is
never exposed to a specific trigger. In addition, different
alleles might differently respond to the same environmen-
tal condition. Consequently, each exposed individual’s risk
of a given disease phenotype is determined by the partic-
ular allele of an individual carrier. Thus, further and larger
investigations are certainly needed. For example, genomic,
transcriptomic, and epigenomic investigations may even-
tually lead to a better understanding of the role of this
pathway and inflammation in vascular aorta ageing and
sporadic TAA.
In the complex, our results, although based on a rela-
tively reduced number of cases and controls, seem to
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suggest that the mean of blood leukocyte TFR telomere
length and mean RTA values might be the predictor
biomarkers for sporadic TAA. These data are in agreement
with the results of other studies performed in aorta dis-
eases, i.e., particularly in abdominal aorta aneurysms
(Atturu et al. 2010; Yan et al. 2011; Björck et al. 2011).
However, they are opposite to those of Salonurmi’s group
study performed in a population affected by ascending
aorta aneurysms (Huusko et al. 2012). In particular, a
longer mean relative telomere length was observed in
cases when compared to that of controls (Huusko et al.
2012). These discordances might be due to different fac-
tors. Differently to cases selected in the study of
Salonurmi’s group (Huusko et al. 2012), our patients were
older and characterized to have significant associations
with a typical systemic inflammatory phenotype of senes-
cence cells, the aorta associated senescence secretory
phenotype (AASSP), fruit of the probable activation of
the inflammatory pathways (Balistreri et al. 2013d;
Sikora et al. 2013; Ruvolo et al. 2014), including partic-
ularly the TLR4-mediated signaling pathway (Balistreri
et al. 2009, 2014a, b; Ruvolo et al. 2014). They also
showed a significant overrepresentation of some genetic
variants of this pathway as indicated in this and previous
studies (Balistreri et al. 2013b, c, 2014a, b; Ruvolo et al.
2014). In addition, they had different clinical conditions
and aorta abnormalities than those analyzed in
Salonurmi’s group study (Huusko et al. 2012; Balistreri
et al. 2014a, b; Ruvolo et al. 2014). In particular, the
phenotype III with elevated cystic medial degeneration,
elevated elastic fragmentation, plurifocal medial apopto-
sis, and increased amounts of metalloproteinase-9 preva-
lently characterized the aorta tissue samples of our cases
(Balistreri et al. 2014a, b; Ruvolo et al. 2014). In contrast,
the Salonurmi’s study provided no information about
genetic, systemic, and histological aorta tissue character-
istics of cases (Huusko et al. 2012). Furthermore, we and
the Salonurmi’s group used different methodologies and
samples for detecting telomere length and telomerase
activity (as mentioned in the Introduction section). This
probably might further justify the discordant results ob-
tained. As a consequence, it should be imperative to
consider the problem of different methodologies available
to determine leukocyte telomere length and telomerase
activity to increase the valence of the investigations on
telomere and telomerase activity in aorta aneurysms in
order to identify them as possible predictor biomarkers of
sporadic TAA. This problem represents one of the major
consequences of the large heterogeneity existing in the
literature data on this topic. Thus, a standardization is
much needed as well as the necessity for longitudinal
and larger studies to elucidate these complicated relation-
ships between genetic background and environmental
factors in affecting telomere and telomerase activity sys-
tem and inducing senescence of cardiovascular aorta cells
and onset of sporadic TAA.
As above underlined, we propose to perform future and
larger studies, which will consent to confirm and validate
our data and to suggest leukocyte telomere length and
telomerase activity as predictor biomarkers of sporadic
TAA. Cotemporally, our findings also encourage in
performing further and larger investigations to validate
the key role of the variants related to TLR4 inflammatory
pathway in both telomere/telomerase impairment. This
might permit us to consider the TLR4 pathway as a target
for the development of personalized therapies based, in
our case, on the presence of high responder genotype in
individuals affected by sporadic TAA. On the other hand,
it is well recognized that the TLR4 pathway responds to a
variety of endogenous as well as exogenous ligands
(Balistreri et al. 2009). By responding to endogenous
ligands that are exposed during cellular damage, TLR4
have been implicated in a range of pathological conditions
associated with cardiovascular dysfunction (Pryshchep
et al. 2008; Balistreri et al. 2009, 2014a, b; Eissler et al.
2011; Li et al. 2011; Song et al. 2012; González-Ramos
et al. 2013; Navi et al. 2013). Increasing the knowledge on
the mechanisms involved in TLR4 signaling has encour-
aged the exploration of therapeutic pharmacological mod-
ulation of TLR4 activation in different models of cardio-
vascular diseases, essentially using agonists or antagonists
(Navi et al. 2013). The confirmation of the role of this
pathway and related genetic variants in the pathophysiol-
ogy of sporadic TAA might certainly consent to translate
the data in personalized therapies.
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